Baxter Net Profit Margin 2010-2025 | BAX
Current and historical net profit margin for Baxter (BAX) from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Baxter net profit margin for the three months ending March 31, 2025 was .
| Baxter Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $10.77B | $-0.56B | -5.20% |
| 2024-12-31 | $10.64B | $-0.65B | -6.10% |
| 2024-09-30 | $9.54B | $0.11B | 1.13% |
| 2024-06-30 | $9.44B | $2.48B | 26.22% |
| 2024-03-31 | $9.34B | $2.65B | 28.37% |
| 2023-12-31 | $10.36B | $2.66B | 25.64% |
| 2023-09-30 | $8.97B | $2.59B | 28.91% |
| 2023-06-30 | $9.98B | $-2.85B | -28.60% |
| 2023-03-31 | $9.86B | $-2.46B | -24.94% |
| 2022-12-31 | $10.06B | $-2.43B | -24.19% |
| 2022-09-30 | $13.79B | $-2.38B | -17.23% |
| 2022-06-30 | $13.40B | $1.01B | 7.54% |
| 2022-03-31 | $12.91B | $1.06B | 8.19% |
| 2021-12-31 | $12.15B | $1.28B | 10.57% |
| 2021-09-30 | $12.45B | $1.21B | 9.75% |
| 2021-06-30 | $12.20B | $1.12B | 9.18% |
| 2021-03-31 | $11.82B | $1.07B | 9.04% |
| 2020-12-31 | $11.67B | $1.10B | 9.44% |
| 2020-09-30 | $11.53B | $0.91B | 7.90% |
| 2020-06-30 | $11.41B | $0.92B | 8.10% |
| 2020-03-31 | $11.53B | $0.99B | 8.60% |
| 2019-12-31 | $11.36B | $1.00B | 8.81% |
| 2019-09-30 | $11.14B | $1.32B | 11.85% |
| 2019-06-30 | $11.05B | $1.47B | 13.29% |
| 2019-03-31 | $11.06B | $1.50B | 13.55% |
| 2018-12-31 | $11.10B | $1.55B | 13.93% |
| 2018-09-30 | $11.08B | $1.06B | 9.61% |
| 2018-06-30 | $11.02B | $0.80B | 7.23% |
| 2018-03-31 | $10.79B | $0.72B | 6.67% |
| 2017-12-31 | $10.58B | $0.60B | 5.69% |
| 2017-09-30 | $10.43B | $1.03B | 9.88% |
| 2017-06-30 | $10.28B | $0.91B | 8.85% |
| 2017-03-31 | $10.26B | $1.86B | 18.09% |
| 2016-12-31 | $10.16B | $4.97B | 48.85% |
| 2016-09-30 | $10.12B | $4.93B | 48.68% |
| 2016-06-30 | $10.05B | $4.80B | 47.74% |
| 2016-03-31 | $9.94B | $3.92B | 39.42% |
| 2015-12-31 | $9.97B | $0.97B | 9.71% |
| 2015-09-30 | $10.15B | $1.72B | 16.90% |
| 2015-06-30 | $10.38B | $2.18B | 21.04% |
| 2015-03-31 | $12.06B | $2.37B | 19.67% |
| 2014-12-31 | $13.50B | $2.50B | 18.50% |
| 2014-09-30 | $15.03B | $1.87B | 12.44% |
| 2014-06-30 | $16.03B | $1.95B | 12.14% |
| 2014-03-31 | $15.55B | $2.02B | 12.97% |
| 2013-12-31 | $15.15B | $2.01B | 13.28% |
| 2013-09-30 | $14.33B | $2.18B | 15.22% |
| 2013-06-30 | $14.09B | $2.22B | 15.75% |
| 2013-03-31 | $14.00B | $2.29B | 16.36% |
| 2012-12-31 | $13.94B | $2.33B | 16.69% |
| 2012-09-30 | $14.03B | $2.30B | 16.36% |
| 2012-06-30 | $14.03B | $2.29B | 16.30% |
| 2012-03-31 | $14.00B | $2.24B | 16.02% |
| 2011-12-31 | $13.89B | $2.22B | 16.01% |
| 2011-09-30 | $13.80B | $2.18B | 15.83% |
| 2011-06-30 | $13.54B | $2.13B | 15.75% |
| 2011-03-31 | $13.20B | $2.05B | 15.55% |
| 2010-12-31 | $12.84B | $1.42B | 11.06% |
| 2010-09-30 | $12.82B | $1.57B | 12.24% |
| 2010-06-30 | $12.74B | $1.57B | 12.36% |
| 2010-03-31 | $12.67B | $1.63B | 12.84% |
| 2009-12-31 | $12.56B | $2.21B | 17.55% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.534B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.788B | 27.51 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $144.385B | 30.19 |
| EssilorLuxottica (ESLOY) | France | $135.514B | 0.00 |
| Medtronic (MDT) | Ireland | $103.771B | 14.71 |
| Haleon (HLN) | United Kingdom | $49.845B | 28.36 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.977B | 0.00 |
| ResMed (RMD) | United States | $35.996B | 27.04 |
| GE HealthCare Technologies (GEHC) | United States | $31.796B | 15.10 |
| Agilent Technologies (A) | United States | $31.270B | 20.66 |
| Terumo (TRUMY) | Japan | $27.864B | 36.19 |
| Insulet (PODD) | United States | $22.590B | 88.67 |
| Koninklijke Philips (PHG) | Netherlands | $21.684B | 15.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.137B | 11.65 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.438B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.181B | 21.51 |
| Lantheus Holdings (LNTH) | United States | $5.172B | 13.05 |
| Prestige Consumer Healthcare (PBH) | United States | $4.201B | 18.77 |
| Perrigo (PRGO) | Ireland | $3.629B | 9.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.218B | 23.73 |
| Haemonetics (HAE) | United States | $3.178B | 14.48 |
| Envista Holdings (NVST) | United States | $2.859B | 23.76 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| QuidelOrtho (QDEL) | United States | $2.041B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.788B | 39.96 |
| AtriCure (ATRC) | United States | $1.624B | 0.00 |
| Neogen (NEOG) | United States | $1.343B | 17.19 |
| Acuren (TIC) | United States | $1.288B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.206B | 12.25 |
| Green Thumb Industries (GTBIF) | United States | $1.175B | 26.43 |
| Kestra Medical Technologies (KMTS) | United States | $1.145B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.050B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.933B | 11.93 |
| InMode (INMD) | Israel | $0.906B | 9.13 |
| CeriBell (CBLL) | United States | $0.624B | 0.00 |
| Evolus (EOLS) | United States | $0.616B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.584B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.558B | 0.00 |
| Owens & Minor (OMI) | United States | $0.532B | 4.41 |
| Valneva SE (VALN) | France | $0.529B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.496B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.355B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.336B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.318B | 11.71 |
| Aurora Cannabis (ACB) | Canada | $0.309B | 54.90 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.258B | 21.73 |
| Sanuwave Health (SNWV) | United States | $0.247B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.233B | 10.57 |
| Biote (BTMD) | United States | $0.205B | 5.77 |
| Brainsway (BWAY) | Israel | $0.197B | 52.15 |
| OraSure Technologies (OSUR) | United States | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.189B | 0.00 |
| Omeros (OMER) | United States | $0.189B | 0.00 |
| Quanterix (QTRX) | United States | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.183B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.20 |
| TriSalus Life Sciences (TLSI) | United States | $0.173B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
| Exagen (XGN) | United States | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.117B | 0.00 |
| Agape ATP (ATPC) | $0.112B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 11.17 |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.028B | 37.57 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |